Physician profile
Alan B Silverberg
NPI 1972511848
$2,906.21
in general payments reported to CMS, 2019-2025
20 companies · $36.46 in 2025
The $36.46 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $54.04 · 2021: $344 · 2022: $1,456 · 2023: $364 · 2024: $157 · 2025: $36.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $972.00 | 2022 | |
| Dexcom, INC. | $486.38 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Novo Nordisk INC | $244.98 | 2019-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $203.55 | 2021-2023 | Mounjaro, Retevmo |
| Medtronic, INC. | $169.42 | 2021-2024 | Minimed 780g |
| Radius Health, INC. | $152.28 | 2019 | |
| Abbott Laboratories | $119.01 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.83 | 2019-2022 | |
| Horizon Therapeutics Plc | $90.53 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $84.93 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.47 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $37.25 | 2019 | |
| Mannkind Corporation | $35.22 | 2022 | |
| Amgen INC. | $31.37 | 2019 | |
| Clarus Therapeutics INC. | $30.18 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $24.30 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.94 | 2019-2021 | |
| Abbvie INC. | $19.08 | 2019 | |
| Shire North American Group INC | $13.93 | 2019 | |
| Amryt Pharma Holdings LTD | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Silverberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.